Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson’s Disease

Autor: Jacob S. Daniel, Jyothish P. Govindan, Chandan Kamath, Charles D’Souza, Mohamed A. Adlan, Lakdasa D. Premawardhana

Publikováno v: Clinical Medicine Insights: Endocrinology and Diabetes, Vol 2014, Iss 7, Pp 13-17 (2014)

Externí odkaz: https://doaj.org/article/8c1a048d8d5d4e1b95ba164882039a61

Thymic hyperplasia in Graves' disease - wait and see, or intervene?

Autor: M. A. Adlan, Lakdasa Premawardhana, B MacAleer, Chandan Kamath

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a9918e8bcc86d92c63782b052451405
https://doi.org/10.1530/endoabs.50.ep100

Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy

Autor: M. A. Adlan, Chandan Kamath, SJ Wood, J Govindan, AD Premawardhana, Lakdasa Premawardhana

Publikováno v: Clinical Medicine. 13:407-410

Lithium (Li) may cause multiple endocrinopathies, including hypercalcaemia, thyroid dysfunction and nephrogenic diabetes insipidus (NDI), but rarely in the same patient. The management of NDI remains a challenge. We report on a patient on long-term L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689102ec5c680428154c0611666bc705
https://doi.org/10.7861/clinmedicine.13-4-407

Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema

Autor: B. Rees Smith, Katarzyna Kabelis, Jadwiga Furmaniak, Chandan Kamath, Julia Sanders, Samuel Young, Lakdasa Premawardhana, M. A. Adlan

Publikováno v: Clinical Endocrinology. 77:465-470

Context Sequential conversion of Hashimoto's thyroiditis (HT) to Graves' disease (GD) is uncommon. Distinct immune paradigms, paucity of functioning tissue in long-standing HT, and infrequent conversion of blocking (TBAb) to stimulating (TSAb) thyrot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced692e0a8675297e936d62b87681a44
https://doi.org/10.1111/j.1365-2265.2012.04397.x

Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson's Disease

Autor: Mohamed Adlan, Jacob S. Daniel, J Govindan, Lakdasa Premawardhana, Chandan Kamath, Charles D’Souza

Publikováno v: Clinical Medicine Insights: Endocrinology and Diabetes, Vol 7 (2014)
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 2014, Iss 7, Pp 13-17 (2014)
Clinical Medicine Insights. Endocrinology and Diabetes

Objective We studied the prevalence of endocrine dysfunction in subjects with idiopathic Parkinson's disease (IPD) on newer dopaminergic agents (DA). DA are also used in endocrine hypersecretory states in small doses and we hypothesized that endocrin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b85f50559e785dcc6e30f6202a2f581b
https://doaj.org/article/893153b606c846929c5dcaad041a0f36